Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy

European Journal of Medicinal Chemistry - France
doi 10.1016/j.ejmech.2013.01.023

Related search